This paper is in the following e-collection/theme issue:

Human Factors and Usability Case Studies (739) Mobile Apps for Cancer Care and Cancer Prevention and Screening (196) Innovations and Technology in Cancer Care (400)

Published on in Vol 24, No 8 (2022): August

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/37368, first published .
Usability Evaluation of a Noninvasive Neutropenia Screening Device (PointCheck) for Patients Undergoing Cancer Chemotherapy: Mixed Methods Observational Study

Usability Evaluation of a Noninvasive Neutropenia Screening Device (PointCheck) for Patients Undergoing Cancer Chemotherapy: Mixed Methods Observational Study

Usability Evaluation of a Noninvasive Neutropenia Screening Device (PointCheck) for Patients Undergoing Cancer Chemotherapy: Mixed Methods Observational Study

Authors of this article:

Ganimete Lamaj1 Author Orcid Image ;   Alberto Pablo-Trinidad1 Author Orcid Image ;   Ian Butterworth1 Author Orcid Image ;   Nolan Bell1 Author Orcid Image ;   Ryan Benasutti1 Author Orcid Image ;   Aurelien Bourquard1 Author Orcid Image ;   Alvaro Sanchez-Ferro1 Author Orcid Image ;   Carlos Castro-Gonzalez1 Author Orcid Image ;   Ana Jiménez-Ubieto2 Author Orcid Image ;   Tycho Baumann2 Author Orcid Image ;   Antonia Rodriguez-Izquierdo2 Author Orcid Image ;   Elizabeth Pottier3 Author Orcid Image ;   Anthony Shelton3 Author Orcid Image ;   Joaquin Martinez-Lopez2 Author Orcid Image ;   John Mark Sloan3 Author Orcid Image
Article Authors Cited by (2) Tweetations (6) Metrics

Ganimete Lamaj   1 , BSc ;   Alberto Pablo-Trinidad   1 , PhD ;   Ian Butterworth   1 , MSc ;   Nolan Bell   1 , BSc ;   Ryan Benasutti   1 , BSc ;   Aurelien Bourquard   1 , PhD ;   Alvaro Sanchez-Ferro   1 , MD, PhD ;   Carlos Castro-Gonzalez   1 , PhD ;   Ana Jiménez-Ubieto   2 , PhD ;   Tycho Baumann   2 , MD ;   Antonia Rodriguez-Izquierdo   2 , MD ;   Elizabeth Pottier   3 , MM ;   Anthony Shelton   3 , RN, OCN ;   Joaquin Martinez-Lopez   2 , MD, PhD ;   John Mark Sloan   3 , MD

1 Leuko Labs, Inc, Boston, MA, United States

2 Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain

3 Section of Hematology & Medical Oncology, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA, United States

Corresponding Author: